Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Sep 3;11(17):2235-9.
doi: 10.1016/s0960-894x(01)00412-7.

Evolution of anti-HIV Drug Candidates. Part 3: Diarylpyrimidine (DAPY) Analogues

Affiliations

Evolution of anti-HIV Drug Candidates. Part 3: Diarylpyrimidine (DAPY) Analogues

D W Ludovici et al. Bioorg Med Chem Lett. .

Abstract

The synthesis and anti-HIV-1 activity of a series of diarylpyrimidines (DAPYs) are described. Several members of this novel class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) are extremely potent against both wild-type and a panel of clinically significant single- and double-mutant strains of HIV-1.

Similar articles

See all similar articles

Cited by 33 articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback